Metropolitan Life Insurance Company (MetLife)’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,728
Closed -$48K 187
2024
Q1
$48K Hold
2,728
﹤0.01% 1424
2023
Q4
$43K Hold
2,728
﹤0.01% 1527
2023
Q3
$23.5K Hold
2,728
﹤0.01% 1813
2023
Q2
$21.5K Hold
2,728
﹤0.01% 1893
2023
Q1
$20.3K Buy
2,728
+793
+41% +$7.88K ﹤0.01% 1880
2022
Q4
$22.8K Buy
1,935
+457
+31% +$5.22K ﹤0.01% 1939
2022
Q3
$13.6K Hold
1,478
﹤0.01% 2197
2022
Q2
$14.6K Hold
1,478
﹤0.01% 2197
2022
Q1
$51K Sell
1,478
-4,230
-74% -$137K ﹤0.01% 1582
2021
Q4
$284K Sell
5,708
-821
-13% -$43.3K ﹤0.01% 1771
2021
Q3
$300K Buy
6,529
+400
+7% +$15.9K ﹤0.01% 1766
2021
Q2
$183K Hold
6,129
﹤0.01% 2208
2021
Q1
$125K Sell
6,129
-272
-4% -$5.74K ﹤0.01% 2326
2020
Q4
$107K Sell
6,401
-11
-0.2% -$145 ﹤0.01% 2328
2020
Q3
$70.2K Buy
+6,412
New +$50.7K ﹤0.01% 2404

Other funds holding ASPN

Metropolitan Life Insurance Company (MetLife)'s ASPN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Aspen Aerogels (ASPN) in Q2 2024, closing a stake of 2,728 shares — an estimated $48K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ASPN in Q3 2020 and held it in 15 quarters. The position peaked at $300K in Q3 2021. 222 funds tracked by Wall St. Rank hold ASPN as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Aspen Aerogels position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,728 Aspen Aerogels shares in Q2 2024, an estimated $48K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Aspen Aerogels in Q3 2020 and held it in 15 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Aspen Aerogels position peaked at $300K in Q3 2021.
  • 222 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.